| 1 |
35501312 | Rare and misincorporated DNA N6-methyladenine is a hallmark of cytotoxic stresses for selectively stimulating the stemness and proliferation of glioblastoma cells. | 2022 Apr 30 |
1 |
| 2 |
30724377 | Sensitive detection of hydroxymethylcytosine levels in normal and neoplastic cells and tissues. | 2019 May |
4 |
| 3 |
29428975 | 5-Hydroxymethylcytosine preferentially targets genes upregulated in isocitrate dehydrogenase 1 mutant high-grade glioma. | 2018 Apr |
2 |
| 4 |
28039446 | 5-Hydroxymethylcytosine correlates with epigenetic regulatory mutations, but may not have prognostic value in predicting survival in normal karyotype acute myeloid leukemia. | 2017 Jan 31 |
2 |
| 5 |
26680004 | Loss of 5-hydroxymethylcytosine is linked to gene body hypermethylation in kidney cancer. | 2016 Jan |
1 |
| 6 |
27458708 | Immunohistochemical loss of 5-hydroxymethylcytosine expression in acute myeloid leukaemia: relationship to somatic gene mutations affecting epigenetic pathways. | 2016 Dec |
3 |
| 7 |
27466503 | Isocitrate Dehydrogenase 2 Dysfunction Contributes to 5-hydroxymethylcytosine Depletion in Gastric Cancer Cells. | 2016 Aug |
1 |
| 8 |
24986689 | Characterization of acute myeloid leukemia based on levels of global hydroxymethylation. | 2014 Aug 14 |
1 |
| 9 |
25482556 | DNA hydroxymethylation profiling reveals that WT1 mutations result in loss of TET2 function in acute myeloid leukemia. | 2014 Dec 11 |
2 |
| 10 |
22824796 | Mutations in isocitrate dehydrogenase 1 and 2 occur frequently in intrahepatic cholangiocarcinomas and share hypermethylation targets with glioblastomas. | 2013 Jun 20 |
1 |
| 11 |
23634848 | 5-hydroxymethylcytosine and its potential roles in development and cancer. | 2013 May 1 |
2 |
| 12 |
22688054 | Nuclear exclusion of TET1 is associated with loss of 5-hydroxymethylcytosine in IDH1 wild-type gliomas. | 2012 Aug |
1 |
| 13 |
22772731 | IDH1 mutations inhibit multiple α-ketoglutarate-dependent dioxygenase activities in astroglioma. | 2012 Sep |
1 |
| 14 |
21251613 | Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of α-ketoglutarate-dependent dioxygenases. | 2011 Jan 18 |
2 |
| 15 |
21690245 | TET2 promoter methylation in low-grade diffuse gliomas lacking IDH1/2 mutations. | 2011 Oct |
1 |